Conclusions
pneumonia, ARDS, VFDs
ARDS, PNEUMONIA
In this phase 2 study of Japanese patients with ARDS caused by pneumonia, treatment with invimestrocel plus standard treatment compared with standard treatment alone resulted in no significant difference in the number of VFDs over 28 days but may result in improved survival. Further studies in blinded, placebo-controlled trials are required to further evaluate early withdrawal from the ventilator and reduced mortality with the addition of invimestrocel to standard treatment.